|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07C 217/74 | |
| C07C 215/64 | |||
| C07D 265/16 | |||
| C07B 59/00 |
| (11) | Number of the document | 3103790 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16179352.6 |
| Date of filing the European patent application | 2008-03-13 | |
| (97) | Date of publication of the European application | 2016-12-14 |
| (45) | Date of publication and mention of the grant of the patent | 2018-05-09 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 895049 P | 2007-03-15 | US | |
| 944399 P | 2007-06-15 | US |
| (72) |
GANT, Thomas G., US
SEPEHR, Sarshar, US
WOO, Soon Hyung, US
|
| (73) |
Auspex Pharmaceuticals, Inc.,
1261 Liberty Way, Suite C, Vista, CA 92081-8356,
US
|
| (54) | SUBSTITUTED PHENETHYLAMINE WITH SEROTONINERGIC AND/OR NOREPINEPHRINERGIC ACTIVITY |
| SUBSTITUTED PHENETHYLAMINE WITH SEROTONINERGIC AND/OR NOREPINEPHRINERGIC ACTIVITY |